![]() |
Volumn 64, Issue 2-3, 2001, Pages 271-275
|
Modest adjunctive benefit with transcranial magnetic stimulation in medication-resistant depression
|
Author keywords
Depression; Drug resistant; Transcranial magnetic stimulation
|
Indexed keywords
AMITRIPTYLINE;
ANTIDEPRESSANT AGENT;
BENZODIAZEPINE DERIVATIVE;
CITALOPRAM;
CLOMIPRAMINE;
FLUOXETINE;
FLUVOXAMINE;
IMIPRAMINE;
MAPROTILINE;
MIRTAZAPINE;
OLANZAPINE;
PAROXETINE;
PLACEBO;
SERTRALINE;
TRANILCIPROMINE;
TRAZODONE;
UNCLASSIFIED DRUG;
VALPROIC ACID;
VENLAFAXINE;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DEPRESSION;
DRUG EFFECT;
DRUG EFFICACY;
FEMALE;
HAMILTON SCALE;
HUMAN;
LONG TERM CARE;
MALE;
PREFRONTAL CORTEX;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
RATING SCALE;
TRANSCRANIAL MAGNETIC STIMULATION;
TREATMENT OUTCOME;
ANTIDEPRESSIVE AGENTS;
COMBINED MODALITY THERAPY;
DEPRESSIVE DISORDER, MAJOR;
DOUBLE-BLIND METHOD;
DRUG RESISTANCE;
ELECTROMAGNETICS;
FEMALE;
FOLLOW-UP STUDIES;
FUNCTIONAL LATERALITY;
HUMANS;
MALE;
MIDDLE AGED;
PREFRONTAL CORTEX;
SKULL;
TREATMENT OUTCOME;
|
EID: 0035057673
PISSN: 01650327
EISSN: None
Source Type: Journal
DOI: 10.1016/S0165-0327(00)00223-8 Document Type: Article |
Times cited : (101)
|
References (14)
|